Newsfeeds Archive - Page 32 of 56

4 minute read

Benzinga’s Psychedelics Capital Conference: Meet An Unrivaled Group Of Advisors And Fund Partners

March 7, 6:28 PM

The upcoming Psychedelics Capital Conference constitutes Benzinga’s effort to provide an exclusive opportunity to meet, connect with and learn from some of the most knowledgeable people in the space.

BWVI

6 minute read

Psyched: 9 US Reform Bills, Ayahuasca ‘A Release’ For Prince Harry, At-Home Therapy & More

By Lara Goldstein

March 7, 11:29 AM

Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been held and various measures have been considered around the legalization of psychedelics. Let’s go over the latest proposed regulations.

AGNPF

2 minute read

Benzinga’s Psychedelics Capital Conference Is Open For Business: Meet Our Renowned Keynote Speaker

By Lara Goldstein

March 6, 10:21 PM

This year is the second edition of what is rapidly becoming the place to be for those interested in or already involved in the psychedelics space: new deals get closed, money gets raised and knowledge is shared at this not-to-be-missed gathering for investors, key partners as well as the general public.

NFLX

2 minute read

Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce

By Lara Goldstein

March 6, 3:49 PM

The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as its plan to streamline its workforce with significant layoffs.

ATAI

3 minute read

Here Are The Year’s Highest Priced Psychedelics Stocks In US Markets

By Lara Goldstein

March 6, 1:41 PM

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.

ATAI

3 minute read

Cybin: Positive Clinical Trial On Psilocybin Analog For Major Depression & Updates On DMT Analog Program

By Lara Goldstein

March 2, 11:43 PM

Psychedelics biotech company Cybin Inc.

CYBN

2 minute read

MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production

By Lara Goldstein

March 2, 3:50 PM

PharmAla To Be Exclusive MDMA Supply Partner To Awakn Life Sciences Effective immediately, MDXX class molecules producer PharmAla Biotech Holdings Inc. will become the exclusive MDMA supplier to Awakn Life Sciences (OTCMKTS: AWKNF).

AWKNF

2 minute read

Braxia Scientific’s Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals

By Lara Goldstein

March 2, 3:26 PM

Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec.

BRAXF

2 minute read

Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program

By Lara Goldstein

March 1, 10:30 PM

Canadian clinical-stage psychedelics developer Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) will start trading its Class A common shares following a 4-to-1 stock split towards increasing liquidity.

AGNPF

1 minute read

Lucy Scientific Secures First Delivery Of Psilocybin To Israel Following DMT & 5-MeO-DMT

By Lara Goldstein

February 28, 6:29 PM

Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Canada-based psychedelics manufacturing company, has inked its first commercial sale to the prestigious Hadassah BrainLabs, also known as the Center for Psychedelics Research at the Hadassah Medical Center at Hebrew University in Jerusalem.

LSDI